Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Procaps Group ( (PROCF) ) is now available.
On July 14, 2025, Procaps Group announced the appointment of two new directors, Fernando Moreira Muniz and Carlos Romero-Camacho, to its Board of Directors. This move fills vacancies left by recent resignations and strengthens the company’s governance structure. Mr. Moreira Muniz will also join the Audit Committee, while Mr. Romero-Camacho will serve on the Compensation and Nominating Committees. These appointments are expected to enhance the company’s strategic direction and operational oversight.
More about Procaps Group
Procaps Group, S.A. is a company operating in the pharmaceutical industry, providing a range of healthcare products and services. It is based in Luxembourg and focuses on markets in Eastern Europe and Latin America.
Average Trading Volume: 2,037
Technical Sentiment Signal: Sell
Current Market Cap: $3.23B
Find detailed analytics on PROCF stock on TipRanks’ Stock Analysis page.